Navigation Links
Urgent® PC Clinical Studies Results Scheduled for Presentation at International Continence Society
Date:8/15/2011

MINNETONKA, Minn., Aug. 15, 2011 /PRNewswire/ -- Uroplasty, Inc. (Nasdaq: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that the results of two clinical studies using Uroplasty's Urgent® PC Neuromodulation System are scheduled to be presented at the International Continence Society meeting, August 29-September 2, 2011 in Glasgow, Scotland.  

"These data from on-going clinical studies continue to demonstrate the long-term efficacy of percutaneous tibial nerve stimulation (PTNS) delivered via Urgent PC in the treatment of overactive bladder syndrome," said David Kaysen, President and CEO of Uroplasty.  "The studies build on a growing body of evidence that validates the treatment protocol, usefulness with both young and elderly patients, and the durability of the improvements with continued PTNS therapy."  

ICS Presentations

  • SUmiT Trial Outcomes: Clinical Insights into Percutaneous Tibial Nerve Stimulation, presented by Dr. Peter Sand, NorthShore University Health, Chicago, IL
  • Demonstrated that results are consistent for patients regardless of age
  • Demonstrated that improvement occurs throughout the series of 12 initial treatments, with more improvement occurring during treatments 7 through 12
  • Treatment Interval Frequency of Percutaneous Tibial Nerve Stimulation: 18-Month Results from the STEP Study, presented by Dr. Kenneth Peters, William Beaumont Hospital, Royal Oak, MI
  • Responders to the initial series of 12 treatments treated with regular PTNS therapy, on an average of once per month, sustained their improvements in voiding symptoms and Quality of Life measures throughout 18 months of therapy  

  • About Uroplasty Uroplasty, Inc., headquartered in Minnetonka, Minnesota,
    '/>"/>

    SOURCE Uroplasty, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. Coverage Initiated by Two Regional Medicare Carriers for Posterior Tibial Nerve Stimulation (PTNS) Delivered Via Uroplastys Urgent® PC Neuromodulation System
    2. Additional Regional Medicare Carrier Initiates Coverage for Posterior Tibial Nerve Stimulation (PTNS) Delivered via Uroplastys Urgent® PC Neuromodulation System
    3. Uroplasty Announces Expanded Insurance Coverage of Posterior Tibial Nerve Stimulation (PTNS) Delivered Using the Urgent® PC Neuromodulation System
    4. Two Additional Private Payers Provide Coverage for Posterior Tibial Nerve Stimulation Delivered Using the Uroplasty Urgent® PC Neuromodulation System
    5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
    6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
    7. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
    8. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    9. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
    10. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
    11. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/21/2015)... 2015 Oxfordshire ... more than doubled its overseas sales in just 4 ... winning the Queen,s Award for Enterprise, for Outstanding Achievement ... first HealthScience Communications consultancy, helping its clients bring new ... Having more than doubled its exports in just 4 ...
    (Date:4/21/2015)... Cardiologists at Henry Ford Hospital have implanted a device that ... heartbeat. With only handful of hospitals in the ... to add another option to its arsenal of tools for ... to pump. "This is a first in ... at a non-clinical trial site," says cardiologist Claudio Schuger ...
    (Date:4/21/2015)...  St. Vincent Healthcare is raising the bar ... strict disinfection routines, St. Vincent Healthcare is now also ... germs, like Ebola, methicillin-resistant Staphylococcus aureus ... patients during their hospital stay. ... http://photos.prnewswire.com/prnh/20150420/199749LOGO ...
    Breaking Medicine Technology:Queen's Award Crowns Achievements of Local Consultancy 2Queen's Award Crowns Achievements of Local Consultancy 3Queen's Award Crowns Achievements of Local Consultancy 4Queen's Award Crowns Achievements of Local Consultancy 5Stroke Risk Caused by Abnormal Heart Rhythm Reduced Without Blood Thinners 2Stroke Risk Caused by Abnormal Heart Rhythm Reduced Without Blood Thinners 3St. Vincent Healthcare Deploys Germ-Killing Robot to Prevent Infection, Protect Patients During Hospital Visits 2St. Vincent Healthcare Deploys Germ-Killing Robot to Prevent Infection, Protect Patients During Hospital Visits 3
    ... Demonstrates Increased Dermal Penetration of TPM/Lidocaine Compared to Topical ... MELBOURNE, Australia, Dec. 8 Phosphagenics Limited ("Phosphagenics") (ASX: POH; ... phase 1 clinical trial that examined the ability of ... the pain relief drug, lidocaine, safely into humans. The ...
    ... first vaccine candidate for the prevention of RSV , ... Novavax, Inc. (Nasdaq: NVAX ) announced today that ... University of Massachusetts Medical School , will be presenting ... for the prevention of respiratory syncytial virus ("RSV") at the ...
    Cached Medicine Technology:Positive Phase 1 Clinical Trial Results for Transdermal Lidocaine 2Positive Phase 1 Clinical Trial Results for Transdermal Lidocaine 3Novavax Announces Preclinical Data for Respiratory Syncytial Virus Vaccine Candidate 2
    (Date:4/21/2015)... 21, 2015 On April 2, 2015, ... to Achieve Kylie Jenner Lips With Disastrous ... injured themselves while attempting an at-home lip augmentation ... is that creating an airlock around one’s mouth for ... plump and achieve Kylie Jenner’s now famous pout. (see: ...
    (Date:4/21/2015)... April 21, 2015 “ ZeroWire ” ... Tech Report, which takes a look at the latest ... Scott Steinberg, a special reporter for NewsWatch and a ... how ZeroWire is a security system and lifestyle management ... there were over 2 million burglaries in 2010. It ...
    (Date:4/21/2015)... Lewisville, TX (PRWEB) April 21, 2015 ... (NYSE:ADPT) announced today it is opening its first freestanding ... located in Chandler, Arizona and will be licensed under ... of the Dignity Health and Adeptus Health joint venture. ... Chandler Regional and Mercy Gilbert Medical Centers said the ...
    (Date:4/21/2015)... Wireless Analytics, LLC , a pioneering ... the Boston Business Journal as the 25th fastest-growing private ... a recent event celebrating the 2015 Pacesetters, the ... companies in Massachusetts. , Wireless Analytics was ranked among ... the fastest revenue growth from 2011 through 2014. ...
    (Date:4/21/2015)... 2015 The report “Dermatitis ... analysis on the therapeutic development for Dermatitis. ... identifying new targets and MOAs to produce ... TOC is available @ http://www.rnrmarketresearch.com/dermatitis-pipeline-review-h1-2015-market-report.html ... players involved in the therapeutic development for ...
    Breaking Medicine News(10 mins):Health News:Celebrity Cosmetic Surgeon Comments on Report of Teen Girls Injuring Themselves Attempting Kylie Jenner-Inspired Twitter Challenge 2Health News:A Leader in Home Security was Featured on NewsWatch Television 2Health News:Dignity Health and Adeptus Health to Open First Freestanding Emergency Room in Chandler, Arizona 2Health News:Dignity Health and Adeptus Health to Open First Freestanding Emergency Room in Chandler, Arizona 3Health News:Wireless Analytics Ranked as 25th Fastest Growing Private Company in Massachusetts 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Dermatitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 4
    ... - Health Professionals Calling for Further Guidance From Department ... plastic baby bottles has,been making headlines in North America, ... that 92%(1) of mums are not aware of the ... Us are phasing out,all baby bottles containing Bisphenol-A and ...
    ... A new report, funded and released by,Avalere Health, showed ... its,CY 2008 Part D Formulary Reference File. In response, ... Medicare offerings in 2008,resulting in significantly smaller Part D ... driven in part to remove hundreds of prescription,drugs that ...
    ... A large genetic study in mice has identified hundreds of ... DNA of more than 500 lymphomas to find the cancer ... mutations in total, which together implicate almost 350 regions in ... correspond to genes known to be involved in human cancers ...
    ... focuses on solving real-world problems ... in radiology, ... in radiology and medical image and information management solutions,today announced that its ... at the SIIM 2008,Annual Meeting in Seattle, WA, from May 15 to ...
    ... Life and Casualty,Company, a national life and health insurer, ... Alzheimer,s Association Rita Hayworth Gala for,their support of the ... "Bankers Life has organized Forget Me Not Days over ... 2003 to support both national and,local efforts," said Harry ...
    ... the use of pacemakers,implantable cardioverter-defibrillators (ICDs) and ... May 15 The American College,of Cardiology ... Heart Rhythm,Society (HRS) have jointly released updated ... for Device-Based Therapy of,Cardiac Rhythm Abnormalities are ...
    Cached Medicine News:Health News:Bounty Poll Reveals British Mums in the Dark Over Bisphenol-A in Baby Bottles 2Health News:Avalere Report Shows Unapproved Prescription Drugs Dropped from CMS Formulary Reference File 2Health News:Avalere Report Shows Unapproved Prescription Drugs Dropped from CMS Formulary Reference File 3Health News:Avalere Report Shows Unapproved Prescription Drugs Dropped from CMS Formulary Reference File 4Health News:Connecting cancer genes 2Health News:AMICAS Focuses on the Future of Radiology IT at SIIM 2008 2Health News:AMICAS Focuses on the Future of Radiology IT at SIIM 2008 3Health News:Bankers Life and Casualty Company Named Corporate Honoree at Alzheimer's Association Chicago Rita Hayworth Gala 2Health News:The American College of Cardiology, American Heart Association and the Heart Rhythm Society Release Updated Cardiac Device-Based Therapy Guidelines 2Health News:The American College of Cardiology, American Heart Association and the Heart Rhythm Society Release Updated Cardiac Device-Based Therapy Guidelines 3Health News:The American College of Cardiology, American Heart Association and the Heart Rhythm Society Release Updated Cardiac Device-Based Therapy Guidelines 4
    Lacrimal Cannulas, 19 g. shaft tapering to 23 g. cannula, straight. Overall length 37.5 mm. 5/box....
    Anterior Chamber Needle, 27 g., 5 mm from bend to tip. Overall length 22 mm. 5/box....
    Anterior Chamber Needle, 25 g. Angled. 9 mm angled tip. Overall length 19 mm. 5/box....
    Hydrodissection / Aspiration Cannula, 25 g. Straight with U-tip. U-shaped tip allows aspiration and irrigation at the 12 o'clock position. Overall length 18 mm. 5/box....
    Medicine Products: